| Product Code: ETC8930945 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, North Macedonia continued to heavily rely on imports of levodopa, with top suppliers including China, India, Italy, Germany, and Canada. The market concentration, as measured by the HHI index, remained very high, indicating dominance by a few key players. Despite an overall negative compound annual growth rate (CAGR) from 2020 to 2024, there was a significant surge in growth in 2024 with a growth rate of 175.38%, suggesting a potential shift or emerging opportunities in the market for levodopa imports in North Macedonia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Republic of Macedonia Levodopa Market Overview |
3.1 Republic of Macedonia Country Macro Economic Indicators |
3.2 Republic of Macedonia Levodopa Market Revenues & Volume, 2021 & 2031F |
3.3 Republic of Macedonia Levodopa Market - Industry Life Cycle |
3.4 Republic of Macedonia Levodopa Market - Porter's Five Forces |
3.5 Republic of Macedonia Levodopa Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.6 Republic of Macedonia Levodopa Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Republic of Macedonia Levodopa Market Revenues & Volume Share, By Distribution Channels, 2021 & 2031F |
4 Republic of Macedonia Levodopa Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Republic of Macedonia Levodopa Market Trends |
6 Republic of Macedonia Levodopa Market, By Types |
6.1 Republic of Macedonia Levodopa Market, By Form |
6.1.1 Overview and Analysis |
6.1.2 Republic of Macedonia Levodopa Market Revenues & Volume, By Form, 2021- 2031F |
6.1.3 Republic of Macedonia Levodopa Market Revenues & Volume, By Tablets, 2021- 2031F |
6.1.4 Republic of Macedonia Levodopa Market Revenues & Volume, By Capsules, 2021- 2031F |
6.1.5 Republic of Macedonia Levodopa Market Revenues & Volume, By Powder, 2021- 2031F |
6.1.6 Republic of Macedonia Levodopa Market Revenues & Volume, By Liquid, 2021- 2031F |
6.2 Republic of Macedonia Levodopa Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Republic of Macedonia Levodopa Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Republic of Macedonia Levodopa Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3 Republic of Macedonia Levodopa Market, By Distribution Channels |
6.3.1 Overview and Analysis |
6.3.2 Republic of Macedonia Levodopa Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Republic of Macedonia Levodopa Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 Republic of Macedonia Levodopa Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.3.5 Republic of Macedonia Levodopa Market Revenues & Volume, By Other, 2021- 2031F |
7 Republic of Macedonia Levodopa Market Import-Export Trade Statistics |
7.1 Republic of Macedonia Levodopa Market Export to Major Countries |
7.2 Republic of Macedonia Levodopa Market Imports from Major Countries |
8 Republic of Macedonia Levodopa Market Key Performance Indicators |
9 Republic of Macedonia Levodopa Market - Opportunity Assessment |
9.1 Republic of Macedonia Levodopa Market Opportunity Assessment, By Form, 2021 & 2031F |
9.2 Republic of Macedonia Levodopa Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Republic of Macedonia Levodopa Market Opportunity Assessment, By Distribution Channels, 2021 & 2031F |
10 Republic of Macedonia Levodopa Market - Competitive Landscape |
10.1 Republic of Macedonia Levodopa Market Revenue Share, By Companies, 2024 |
10.2 Republic of Macedonia Levodopa Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |